HEARING INNOVATIONS ANNOUNCES PATENTED HISONIC-TRD TINNITUS RELIEF DEVICE NOW AVAILABLE TO CONSUMERS

Hearing Innovations' patented HiSonic-TRD Tinnitus Relief Device is now available to consumers. First and only device to use low-level ultrasonic to treat and relieve severe tinnitus symptoms. More than 50 million tinnitus sufferers nationwide hear "ringing in the ears," 12 million suffer from severe tinnitus.

NEWS RELEASE

HEARING INNOVATIONS ANNOUNCES PATENTED HISONIC-TRD TINNITUS RELIEF DEVICE NOW AVAILABLE TO CONSUMERS

-- First and Only Device to Use Low-Level Ultrasound to Treat and Relieve Severe Tinnitus Symptoms

--More than 50 Million Tinnitus Sufferers Nationwide Hear Ringing In The Ears"

--12 Million Suffer from Severe Tinnitus

(Farmingdale, NY: December 16, 2002) -- Hearing Innovations Incorporated announced today that its tinnitus relief device --the HiSonic-TRD-- is now available to tinnitus sufferers. This breakthrough technology is the first and only device to use low-level ultrasound to treat and relieve tinnitus symptoms. Hearing Innovations received a U.S. patent for the exclusive and protected right for the use of ultrasound to treat individuals with tinnitus. The company received 510(k) marketing clearance for the HiSonic-TRD earlier this year from the U.S. Food and Drug Administration (FDA) based on positive results from its clinical safety and efficacy study and has been involved in the manufacturing process in recent months in anticipation of the launch of this announcement.

The HiSonic-TRD is intended to be used for tinnitus habituation therapy and tinnitus masking therapy. The HiSonic-TRD provides immediate, effective and safe relief from the severe symptoms of tinnitus through bone-conducted ultrasound.

Tinnitus is the term for noises which are heard in the ears" or in the head." Often described as a ringing," these noises are also described as buzzing, whistling, hissing, pulsing or other sounds that do not come from an external source. According to The American Tinnitus Association, more than 50 million American adults have tinnitus to some degree. Of that number, 12 million suffer from severe tinnitus, causing sufferers to seek medical attention for loss of concentration, sleep problems and psychological distress. Many patients are so seriously debilitated that they cannot function on a normal, day-to-day basis due to extreme distress, depression and, in the worst cases, suicidal tendencies.

Ken Coviello, CEO of Hearing Innovations, states, Tinnitus is a debilitating condition for millions of sufferers. We believe that the HiSonic-TRD will provide many patients with significant relief from their severe symptoms."

Hearing Innovations HiSonic-TRD is now being made available to consumers by prescription from their licensed audiologist, Otolaryngologist (Ear, Nose & Throat physician) or local hearing center.

Tinnitus (pronounced tin-night-us" or tin-nit-us") has a range of causes. While there are many types of treatments that have been used on patients, many sufferers have not yet been able to find a treatment that successfully treats their affliction. In fact, despite the widespread incidence of tinnitus, Hearing Innovations believes that limited attention has been focused on this problem.

The exclusive manufacturer for Hearing Innovations HiSonic-TRD is Misonix Incorporated (NASDAQ NM: MSON), a company that develops, manufactures and/or markets medical, scientific and industrial ultrasonic and air pollution systems and also owns a minority equity position in Hearing Innovations Incorporated.

Hearing Innovations has conducted safety and efficacy studies at the University of Oregon Tinnitus Clinic, the University of Illinois Bioacoustics Research Laboratory and the University at Buffalo Speech-Language and Hearing Clinic.

Since 2000, Hearing Innovations has been marketing a similarly-named product, the HiSonic, a non-invasive ultrasonic bone conduction hearing device for the profoundly deaf.

Hearing Innovations Incorporated is a privately held corporation located at 1938 New Highway in Farmingdale, New York. For more information about the HiSonic-TRD, call Hearing Innovations at (631) 927-9100 or e-mail them at info@hearinginnovations.com.

###############

For Immediate Release

Contact:

-Andrew Jarchin, The Jarchin Group (631) 427-7188, info@jarchin.com

                    

-Ken Coviello, Hearing Innovations (631) 927-9100, info@hearinginnovations.com

Product photo available upon request.

**************************************

Andrew Jarchin

THE JARCHIN GROUP, INC.

Marketing and Public Relations

1160 E. Jericho Turnpike

Huntington, NY 11743

Phone: (631) 427-7188

Fax: (631) 427-7189

e-mail: info@jarchin.com

**************************************


Contact Information
Andrew Jarchin
The Jarchin Group, Inc.
631-427-7188

Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy